Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.42B | 11.83B | 9.26B | 7.97B | 7.65B | 5.91B |
Gross Profit | 4.40B | 4.53B | 3.69B | 3.56B | 3.28B | 2.43B |
EBITDA | 1.11B | 1.44B | 1.32B | 1.27B | 1.54B | 822.88M |
Net Income | 390.05M | 341.31M | 350.13M | 399.44M | 550.01M | 107.34M |
Balance Sheet | ||||||
Total Assets | 8.94B | 9.27B | 8.53B | 7.48B | 7.66B | 6.17B |
Cash, Cash Equivalents and Short-Term Investments | 2.92B | 2.52B | 2.54B | 3.31B | 3.89B | 2.86B |
Total Debt | 9.00M | 0.00 | 45.43M | 0.00 | 0.00 | 0.00 |
Total Liabilities | 4.01B | 4.15B | 3.61B | 2.75B | 3.16B | 2.17B |
Stockholders Equity | 4.93B | 5.12B | 4.92B | 4.73B | 4.50B | 4.00B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.35B | -239.89M | -394.04M | 1.14B | -266.27M |
Operating Cash Flow | 0.00 | 1.39B | 876.58M | 910.61M | 1.98B | 555.91M |
Investing Cash Flow | 0.00 | -1.20B | -1.70B | -1.31B | -899.94M | -822.22M |
Financing Cash Flow | 0.00 | -215.24M | -222.35M | -169.65M | -53.25M | -121.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥1.18T | 19.50 | 17.11% | 3.81% | 20.18% | 23.93% | |
76 Outperform | ¥184.46B | 19.76 | 2.36% | 10.87% | 27.25% | ||
74 Outperform | ¥1.45T | 29.41 | 1.53% | 33.00% | 21.00% | ||
69 Neutral | ¥2.66T | 35.71 | 16.06% | 0.69% | 10.25% | 12.61% | |
68 Neutral | ¥241.23B | 15.39 | 6.62% | 2.45% | 9.02% | -0.57% | |
67 Neutral | ¥1.15T | 22.20 | 1.41% | 4.39% | 7.80% | ||
65 Neutral | ¥18.80B | 32.40 | 0.90% | 22.72% | 71.04% |